ABBOTT INDIA
|
The Current P/S Ratio of ABBOTT INDIA is 9.80.
Share Price | ₹27,043.4 | May 13,2024 |
Market Cap | ₹57,332.0 Cr | |
Sales-TTM | ₹5,848.9 Cr | TTM-Standalone Results |
Price/Sales | 9.80x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of ABBOTT INDIA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹57,332.0 Cr] as on May 13,2024
(/) Sales [ ₹5,848.9 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 9.80x ]
Thus, for ABBOTT INDIA , the investors are currently willing to pay '9.80 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ABBOTT INDIA !
The chart below summarizes the trend in P/S Ratio of ABBOTT INDIA over the last five years.
Historical PS (Price/Sales) ratio chart of ABBOTT INDIA
PS Ratio Performance Analysis for ABBOTT INDIA
- ABBOTT INDIA 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 7.21x.
- ABBOTT INDIA 's operated at median p/e ratio of 7.65x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ABBOTT INDIA 's p/e ratio peaked in Mar2023 at 8.77x.
- ABBOTT INDIA 's p/e ratio hit its five-year low in Mar2019 of 4.21x.
How does ABBOTT INDIA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
ABBOTT INDIA | 5,848.9 | 9.80 | 57,332.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 47,444.6 | 7.72 | 366,103.0 |
CIPLA LTD | 25,774.1 | 4.43 | 114,230.0 |
DR REDDYS LABORATORIES LTD | 28,011.1 | 3.52 | 98,732.2 |
ZYDUS LIFESCIENCES LTD | 19,024.2 | 5.25 | 99,939.2 |
DIVIS LABORATORIES LTD | 7,492.8 | 13.87 | 103,916.0 |
MANKIND PHARMA LTD | 9,946.3 | 8.78 | 87,324.4 |
TORRENT PHARMACEUTICALS LTD | 10,474.0 | 8.42 | 88,139.6 |
LUPIN LTD | 20,010.8 | 3.84 | 76,919.2 |
AUROBINDO PHARMA LTD | 27,894.7 | 2.47 | 69,014.8 |
ALKEM LABORATORIES LTD | 12,634.4 | 4.93 | 62,285.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ABBOTT INDIA 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.47x |
Max industry PS | 13.87x |
Median industry PS | 5.25x |
Average industry PS | 6.64x |
You may also like the below Video Courses